Browsing by Author Emberson, Jonathan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2016Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisChalmers, John; Rodgers, Anthony; Anderson, Simon G; Callender, Thomas; Emberson, Jonathan; Emdin, Connor; Ettehad, Dena; Kiran, Amit; Rahimi, Kazem; The George Institute for Global Health; The George Institute for Global HealthBlood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis, The Lancet, vol.387, 10022, 2016,pp 957-967
2014Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataArima, Hisatomi; MacMahon, Stephen William; Neal, Bruce; Patel, Anushka; Perkovic, Vlado; Woodward, Mark; Baigent, C; Emberson, Jonathan; Jackson, Rod; Karmali, Kunal; Lloyd-Jones, Donald; Rahimi, Kazem; Sundström, Johan; Turnbull, Fiona; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthBlood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data, The Lancet, vol.384, 9943, 2014,pp 591-598
2016Chronic kidney disease and the risk of cancer: An individual patient data meta-analysis of 32,057 participants from six prospective studiesChalmers, John; Chapman, Jeremy; Cooper, Bruce; Craig, Jonathan; Harris, David; Mitchell, Paul; Pollock, Carol; Wang, Jie Jin; Wong, Germaine; Baigent, C; Emberson, Jonathan; Lewis, Joshua; Lim, Wai; Prince, Richard L.; Staplin, Natalie; Turner, Robin M; Zoungas, Sophia; The George Institute for Global Health; Western Clinical School: Westmead Institute for Medical Res; Northern Clinical School: Medicine; School of Public Health: Public Health; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Northern Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; School of Public Health: Public HealthChronic kidney disease and the risk of cancer: An individual patient data meta-analysis of 32,057 participants from six prospective studies, BMC Cancer, vol.16, 1, 2016,pp 1-11
2012Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration RateWoodward, Mark; Coresh, Josef; Emberson, Jonathan; Gansevoort, Ron T; Hammelgarn, Brenda; Jafar, Tazeen; Jee, Sun Ha; Levey, Andrew; Mahmoodi, Bakhtawar; Matsushita, Kunihiro; Polkinghorne, Kevan R.; Shankar, Anoop; Smith, David; Tonelli, Marcello; Warnock, David; Wen, Chi-Pang; The George Institute for International HealthComparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate, JAMA: The Journal of the American Medical Association, vol.307, 18, 2012,pp 1941-1951
2016Cost-effectiveness of simvastatin plus ezetimibe for cardiovascular prevention in CKD: Results of the study of heart and renal protection (SHARP)Craig, Jonathan; Cass, Alan; Emberson, Jonathan; et al, Various; Haynes, Richard; Herrington, William; Kent, Seamus; Lozano-Kuhne, Jingky; Mihaylova, Borislava; Reith, Christina; Schlackow, Iryna; School of Public Health: Public HealthCost-effectiveness of simvastatin plus ezetimibe for cardiovascular prevention in CKD: Results of the study of heart and renal protection (SHARP), American Journal of Kidney Diseases, vol.67, 4, 2016,pp 576-584
2014Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trialsLindley, Richard; Albers, Gregory; Blackwell, Lisa; Bluhmki, Erich; Brott, Thomas; Cohen, Geoff; Davis, Stephen; Donnan, Geoffrey; Emberson, Jonathan; et al, Various; Lees, Kennedy R; Lyden, Patrick; Western Clinical School: Medicine (Westmead)Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials, The Lancet, vol.384, 9958, 2014,pp 1929-1935
2014Effects of lowering LDL cholesterol on progression of kidney diseaseCraig, Jonathan; Agodoa, Lawrence; Baigent, C; Cass, Alan; de Zeeuw, Dick; Emberson, Jonathan; Feldt-Rasmussen, Bo; Fellstrom, Bengt; Haynes, Richard; Herrington, William; Landray, Martin J.; Levin, Adeera; Lewis, David; Reith, Christiana; Walker, Robert; Wheeler, David; School of Public Health: Public HealthEffects of lowering LDL cholesterol on progression of kidney disease, Journal of the American Society of Nephrology, vol.25, 8, 2014,pp 1825-1833
2011The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialCass, Alan; Craig, Jonathan; Neal, Bruce; Baigent, C; Emberson, Jonathan; et al, Various; Krane, Vera; Landray, Martin J.; Reith, Christiana; Tomson, Charles; Wanner, Christoph; Wheeler, David; School of Public Health: Medicine; School of Public Health: Public Health; The George Institute for Global HealthThe effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial, The Lancet, vol.377, 9784, 2011,pp 2181-2192
2012The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsKeech, Anthony (Tony); Simes, Robert John; Baigent, C; Barnes, Elizabeth; Blackwell, L; Braunwald, Eugene; Collins, Rory; de Lemos, James A; Emberson, Jonathan; et al, Various; Gray, Alastair; Mihaylova, Borislava; Voysey, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, The Lancet, vol.380, 9841, 2012,pp 581-590
2015Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trialsKeech, Anthony (Tony); Kirby, Adrienne; O'Connell, Rachel; Blackwell, Lisa; Braunwald, Eugene; Colhoun, Helen; Collins, Rory; Emberson, Jonathan; et al, Various; Fulcher, Jordan; La Rosa, John; Mihaylova, Borislava; Simes, John; Voysey, Merryn; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEfficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials, The Lancet, vol.385, 9976, 2015,pp 1397-1405
2016Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKDMorton, Rachael; Baigent, C; Cass, Alan; Emberson, Jonathan; Gray, Alistair; Haynes, Richard; Herrington, William; Landray, Martin J.; Mihaylova, Borislava; Schlackow, Iryna; Staplin, Natalie D; NH&MRC Clinical Trials CentreImpact of Educational Attainment on Health Outcomes in Moderate to Severe CKD, American Journal of Kidney Diseases, vol.67, 1, 2016,pp 31-39
2016Interpretation of the evidence for the efficacy and safety of statin therapyMacMahon, Stephen William; Neal, Bruce; Rodgers, Anthony; Simes, Robert John; Armitage, Jane; Baigent, C; Blackwell, Lisa; Blumenthal, Roger; Collins, Rory; Danesh, John; DeMets, David L.; Emberson, Jonathan; et al, Various; Reith, Christina; Smith, George Davey; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; NH&MRC Clinical Trials CentreInterpretation of the evidence for the efficacy and safety of statin therapy, The Lancet, vol.388, 10059, 2016,pp 2532-2561
2004The Number Needed To Treat (Nnt) Can Be Adjusted For Bias When The Outcome Is Measured With Error.Irwig, Leslie; Marschner, Ian; Emberson, Jonathan; Walter, Stephen D; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreThe Number Needed To Treat (Nnt) Can Be Adjusted For Bias When The Outcome Is Measured With Error., Journal of Clinical Epidemiology, vol.57,(12),2004,pp 1244-1242
2015What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Cass, Alan; Baigent, C; Emberson, Jonathan; Gray, Alastair; Haynes, Richard; Herrington, William; Kent, Seamus; Landray, Martin J.; Lozano-Kuhne, Jingky; Mihaylova, Borislava; Reith, Christiana; Schlackow, Iryna; School of Public Health: MedicineWhat is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?, BMC Nephrology, vol.16, 1, 2015,pp 1-8